These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14584114)

  • 1. Erythrophagocytosis by myeloid cells in a patient with myeloproliferative disorder.
    Cho SR; Huh JY; Hyun BH
    Yonsei Med J; 2003 Oct; 44(5):928-30. PubMed ID: 14584114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atypical myeloproliferative disorders: a study on 3 cases showing pancytopenia, marrow fibrosis and the absence of splenomegaly].
    Yoshida Y; Yamagishi M; Fukuhara S; Sawada H; Ohkuma M; Uchino H; Nakamura T
    Rinsho Ketsueki; 1984 Mar; 25(3):383-92. PubMed ID: 6471435
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrophagocytosis by dysplastic neutrophils in chronic myelomonocytic leukemia and subsequent transformation to acute myeloid leukemia.
    Etzell J; Lu CM; Browne LW; Wang E
    Am J Hematol; 2005 Aug; 79(4):340-2. PubMed ID: 16044446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myelofibrosis with peripheral myeloblastosis: an acute myeloproliferative disorder.
    Spector JI; Miller S
    Arch Pathol Lab Med; 1978 Nov; 102(11):564-6. PubMed ID: 581448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low-dose combination cytarabine and etoposide for myeloid crisis transformed from unclassified chronic myeloproliferative disorder].
    Matano S; Nakamura S; Kobayashi K; Kaya H; Yoshida T; Sugimoto T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1055-8. PubMed ID: 8687221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging diagnosis in a patient with clear lymphoid immunohistochemical features and myeloid morphology: mixed phenotype acute leukemia with erythrophagocytosis.
    de Leeuw DC; van den Ancker W; Westers TM; Loonen AH; Bhola SL; Ossenkoppele GJ; van de Loosdrecht AA
    Leuk Res; 2011 May; 35(5):693-6. PubMed ID: 21334744
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of biphenotypic blast crisis of unclassified myeloproliferative disorder.
    Kim J; Park CJ; Seo EJ; Lee JH; Yoo SJ; Choi SJ; Chi HS
    Ann Hematol; 2002 Oct; 81(10):603-4. PubMed ID: 12424544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fluorescent dye which recognizes mature peripheral erythrocytes of myeloproliferative disorders.
    Reed JA; Green R; Yamada Y; Kough RH; Williamson P; Schlegel RA
    Cell Biol Int Rep; 1987 Jan; 11(1):55-62. PubMed ID: 3829130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. I. Initial clinical and histologic findings in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages].
    Zankovich R; Thiele J; Mödder B; Steinberg T; Simon KG; Fischer R; Diehl V
    Med Klin (Munich); 1988 Oct; 83(19):617-28. PubMed ID: 3185420
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis.
    Chen F; Zhang C; Wang W; Li L; Yan S; Sun J; Zhang M; Ji C; Hou M
    Leuk Res; 2008 Apr; 32(4):665-7. PubMed ID: 17854891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allopurinol induced pancytopenia in a patient with myeloproliferative disorder].
    Shinagawa A; Itoh T; Komeno T; Komatsu T; Hasegawa Y; Kobayashi T; Kozima H; Ninomiya H; Nagasawa T; Abe T
    Rinsho Ketsueki; 1997 Jan; 38(1):64-71. PubMed ID: 9028164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histomorphologic findings of the bone marrow in chronic myeloproliferative diseases].
    Thiele J; Fischer R
    Z Hautkr; 1989 Oct; 64(10):903-4, 909-12. PubMed ID: 2686247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unusual case of chronic myeloproliferative syndrome].
    Tosato F; Fossaluzza V
    Arch Sci Med (Torino); 1982; 139(4):531-5. PubMed ID: 6891999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelofibrosis in myeloproliferative disorders.
    Srinivasan U; Talvalkar GV; Advani SH
    Indian J Cancer; 1978 Sep; 15(3):37-43. PubMed ID: 294411
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preleukemic erythroblastopenia].
    Horschowski N; Sainty D; Muratore R; Carcassonne Y
    Sem Hop; 1983 Feb; 59(8):549-51. PubMed ID: 6302900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J; Kvasnicka HM; Vardiman J
    Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated histiocytosis X complicated by diffuse erythrophagocytosis: report of two cases.
    Monzon CM; Meyers LG; Hakami N; Luger AM; Bickel JT
    J Med; 1985; 16(5-6):613-24. PubMed ID: 3879497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.